U.S. market Closed. Opens in 1 day 25 minutes

GMED | Globus Medical, Inc. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for GMED we got that it has average fundamentals where Valuation is considered to be fairly valued, Profitability is unacceptably poor, Growth is good and Health is strong.

Valuation (55%)

Company Industry
P/E Ratio (TTM) 122.45 35.44
PEG Ratio (TTM) 0.99 -2.74
P/S Ratio (TTM) 4.54 6.39
P/B Ratio (TTM) 2.75 5.95
P/FCF Ratio (TTM) 38.30 45.33
Price to 5YR AVG Earnings Ratio 58.49 62.55
Price to 5YR AVG FCF Ratio 77.56 34.45

Profitability (30%)

Company Industry
ROA (TTM) 1.80% 5.33%
ROE (TTM) 2.29% 26.24%
Net Profit Margin (TTM) 3.69% 0.94%
ROIC 5YR AVG 8.34% 4.32%

Growth (65%)

4QTR AVG 3YR AVG 5YR AVG
EPS 401.17% 2.23% -1.59%
Revenue 15.57% 10.68% 18.43%
Net Income 467.14% 3.65% 0.61%
Cash Flow 84.08% 16.42% 10.06%

Health (70%)

Company Industry
Current Ratio (TTM) 2.51 2.59
Quick Ratio (TTM) 1.64 1.96
D/E Ratio (TTM) 0.11 -0.04
Interest Coverage (TTM) 21.68 13.08
Piotroski F-Score 4 6
Altman Z-Score 7.81 7.11
LTL to 5YR AVG FCF 3.50 3.62
Shares Outstanding Growth 5YR AVG 3.04% 2.25%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙